AISAP's CARDIO platform is an FDA-cleared, AI-powered software designed to enhance point-of-care ultrasound diagnostics, particularly for structural heart diseases and heart failure. This cloud-based solution integrates seamlessly with various ultrasound devices and electronic health record systems, enabling clinicians to perform real-time, accurate assessments and generate comprehensive reports within minutes. By providing immediate diagnostic insights at the bedside, AISAP aims to improve patient outcomes, streamline clinical workflows, and make advanced cardiac diagnostics more accessible across diverse healthcare settings.